BiotechTube
Home/Pipeline/Novel Formulations & Delivery Systems

Novel Formulations & Delivery Systems

Not Specified

Research/DevelopmentActive

Key Facts

Indication
Not Specified
Phase
Research/Development
Status
Active
Company
JSC Pharmstandard

About JSC Pharmstandard

Founded in 2003, JSC Pharmstandard has solidified its position as Russia's leading pharmaceutical manufacturer, driven by a mission to ensure the availability of affordable, high-quality medicines. Its strategy is built on massive-scale generic drug production, a broad portfolio covering over 30 dosage forms, and active support of national healthcare priorities, including import substitution. Recent partnerships with academic institutions and innovation camps underscore its focus on technological modernization within the generics and biosimilars space to maintain market leadership.

View full company profile

Therapeutic Areas

Broad GenericsCardiovascularCNSAnti-infectivesConsumer Health

Other Not Specified Drugs

DrugCompanyPhase
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
Collaborative Program with FerringPharmaBiomeResearch
Lighthouse Pilot ProductCipheromePilot
Nitric Oxide + Collagen DeliveryJellagenResearch
UndisclosedAutheraPre-clinical
BP1003Bio-Path HoldingsPreclinical
mRNA Therapeutics Platform ApplicationLupagenResearch
PHYRAGOHanda PharmaceuticalsApproved
TASCENSO ODTHanda PharmaceuticalsApproved
AxulinHousey Pharmaceutical Research LaboratoriesCommercial
PBI-04711Phoenix BiotechnologyPre-clinical